Immunovant Inc (IMVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 114,302 | 115,743 | 94,281 | 80,879 | 61,553 |
| Operating Income | -114,302 | -115,743 | -94,281 | -80,879 | -61,553 |
| Other Income | 3,332 | 6,702 | 7,208 | 5,792 | 10,027 |
| Pre-tax Income | -110,970 | -109,041 | -87,073 | -75,087 | -51,526 |
| Income Tax | 152 | 78 | 77 | 232 | -108 |
| Net Income Continuous | -111,122 | -109,119 | -87,150 | -75,319 | -51,418 |
| Net Income | $-111,122 | $-109,119 | $-87,150 | $-75,319 | $-51,418 |
| EPS Basic Total Ops | -0.76 | -0.74 | -0.60 | -0.50 | -0.36 |
| EPS Basic Continuous Ops | -0.76 | -0.75 | -0.60 | -0.51 | -0.36 |
| EPS Diluted Total Ops | -0.76 | -0.74 | -0.60 | -0.50 | -0.36 |
| EPS Diluted Continuous Ops | -0.76 | -0.75 | -0.60 | -0.51 | -0.36 |
| EPS Diluted Before Non-Recurring Items | -0.76 | -0.74 | -0.60 | -0.52 | N/A |
| EBITDA(a) | $-114,203 | $-115,654 | $-94,201 | $-80,815 | $-61,495 |